Literature DB >> 20016289

Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment.

Jingfang Zheng1, Imelda Mercado-Uribe, Daniel G Rosen, Bin Chang, Peishu Liu, Gong Yang, Anais Malpica, Honami Naora, Nelly Auersperg, Gordon B Mills, Robert C Bast, Jinsong Liu.   

Abstract

Papillary differentiation is one of the most common histological features of ovarian cancer, although the underlying mechanism that leads to such differentiation is not known. We hypothesized that human ovarian surface epithelial cells can be transformed into carcinoma with papillary differentiation by overexpressing HER2/neu in these cells. Mice were injected either subcutaneously or intraperitoneally with two immortalized human ovarian surface epithelial cell lines after enforced expression of HER-2/neu. Mice subcutaneously injected with tumor cells from either the T29Nt or T80Nt developed undifferentiated carcinomas. In contrast, mice injected intraperitoneally with T29Nt cells developed papillary carcinoma, and those injected intraperitoneally with T80Nt cells developed undifferentiated carcinoma. Our results demonstrate that ovarian surface epithelial cells can develop into papillary carcinoma in mice, and that the induction of papillary differentiation depends not only on specific genetic modifications but also on the tumor microenvironment and epithelial cell type from ovary from different patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20016289      PMCID: PMC2931318          DOI: 10.4161/cc.9.1.10264

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  23 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix.

Authors:  S L Maines-Bandiera; P A Kruk; N Auersperg
Journal:  Am J Obstet Gynecol       Date:  1992-09       Impact factor: 8.661

3.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

4.  Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

Authors:  Denise C Connolly; Rudi Bao; Alexander Yu Nikitin; Kasie C Stephens; Timothy W Poole; Xiang Hua; Skye S Harris; Barbara C Vanderhyden; Thomas C Hamilton
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

5.  Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes.

Authors:  N Auersperg; S L Maines-Bandiera; H G Dyck; P A Kruk
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

6.  Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.

Authors:  Andrea Flesken-Nikitin; Kyung-Chul Choi; Jessica P Eng; Elena N Shmidt; Alexander Yu Nikitin
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

7.  Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.

Authors:  Alicia A Tone; Heather Begley; Monika Sharma; Joan Murphy; Barry Rosen; Theodore J Brown; Patricia A Shaw
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

8.  A genetically defined model for human ovarian cancer.

Authors:  Jinsong Liu; Gong Yang; Jennifer A Thompson-Lanza; Armand Glassman; Kimberly Hayes; Andrea Patterson; Rebecca T Marquez; Nelly Auersperg; Yinhua Yu; William C Hahn; Gordon B Mills; Robert C Bast
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

9.  Induction of ovarian cancer by defined multiple genetic changes in a mouse model system.

Authors:  Sandra Orsulic; Yi Li; Robert A Soslow; Lynn A Vitale-Cross; J Silvio Gutkind; Harold E Varmus
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

10.  Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line.

Authors:  Sarah L Maines-Bandiera; David Huntsman; Valia S Lestou; Wen-Lin Kuo; Peter C K Leung; R Douglas Horsman; Alice S T Wong; Michelle M M Woo; Keith K C Choi; Calvin D Roskelley; Nelly Auersperg
Journal:  Differentiation       Date:  2004-04       Impact factor: 3.880

View more
  5 in total

1.  Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer.

Authors:  Ludmila Szabova; Chaoying Yin; Sujata Bupp; Theresa M Guerin; Jerome J Schlomer; Deborah B Householder; Maureen L Baran; Ming Yi; Yurong Song; Wenping Sun; Jonathan E McDunn; Philip L Martin; Terry Van Dyke; Simone Difilippantonio
Journal:  Cancer Res       Date:  2012-05-22       Impact factor: 12.701

2.  TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.

Authors:  Zhang Jianwei; Li Qi; Xu Quanquan; Wang Tianen; Wang Qingwei
Journal:  Pathol Oncol Res       Date:  2017-05-02       Impact factor: 3.201

3.  Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.

Authors:  Alison M Karst; Keren Levanon; Ronny Drapkin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

4.  Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases.

Authors:  Lorena Losi; Laura Botticelli; Gianluca Taccagni; Ernesto Longinotti; Cesare Lancellotti; Letizia Scurani; Gian Franco Zannoni
Journal:  Gynecol Oncol Rep       Date:  2018-03-13

5.  Transformation of human ovarian surface epithelial cells by Krüppel-like factor 8.

Authors:  H Lu; X Wang; A M Urvalek; T Li; H Xie; L Yu; J Zhao
Journal:  Oncogene       Date:  2012-12-10       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.